Category: Osteoporosis
Global Osteoporosis
-
Global Stem Cell Therapy for Osteoarthritis Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence ... Read More
-
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030
... global injection pen market is projected to reach USD 74.1 billion by 2030 from USD 47.0 billion in 2024, at a CAGR of 7.9% during the forecast period. The rapid growth in the geriatric population ... Read More
-
Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutics (Non-Hormonal Therapy and Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F
... Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition, 2019-2029F Global Gynecology Drugs Market was valued at USD 5.74 Billion in 2023 and is anticipated to project impressive growth ... Read More
-
Women Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, ORTHO TRI-CY LO (28)), By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others), By Region and Competition, 2019-2029F
... Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome, Others), By Region and Competition, 2019-2029F Global Women Healthcare Market was valued at USD 9.52 Billion in 2023 and is anticipated to project steady growth in ... Read More
-
Bone Densitometers
... at a CAGR of 5.5% over the analysis period 2023-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$264.5 Million by the end ... Read More
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
Anti-Osteoporosis Therapy and Fracture Healing Market Size, Trends, Analysis, and Outlook By Drug (Bi-phosphates, Calcitonin, Estrogen or Hormone Replacement Therapy, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030 The global Anti-Osteoporosis Therapy and Fracture Healing market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Bisphosphonates
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoarthritis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Osteoporosis Diagnostic Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Postmenopausal Osteoporosis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Drug Type (Bisphosphonates, Vitamin D3, Estrogen Agonist/Antagonist, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region, and Competition
... Retail Pharmacies, Others), By Region, and Competition Global Postmenopausal Osteoporosis Treatment Market was valued at USD 9.18 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of ... Read More
-
Postmenopausal Osteoporosis Treatment Market Forecasts to 2030 – Global Analysis By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents and Other Treatment Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography
... Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography According to Stratistics MRC, the Global Postmenopausal Osteoporosis Treatment ... Read More
-
Global Raloxifene Hydrochloride Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Osteoporosis - Global Clinical Trials Review, 2023
... scenario. This report provides top line data relating to the clinical trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Global Osteoarthritis Analgesics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for ... Read More
-
Global Osteoarthritis Analgesics Supply, Demand and Key Producers, 2023-2029
... (2023-2029). Osteoarthritis is an inflammatory disease, and pain is closely related to inflammation. Analgesic drugs for osteoarthritis are mainly divided into two categories: over-the-counter drugs and prescription drugs. There are three main types: injection, oral ... Read More
-
Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 21.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028. Osteoporosis is a disease that causes deterioration of bone tissues and strength. It is diagnosed by performing different scans, such as X-ray, ... Read More
Research Assistance
